<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>ECRI.org Health Technology Forecast</title><link>https://members2.ecri.org/Components/forecast/</link><copyright>Copyright 2010 ECRI</copyright><description>New and Updated Forecast profiles</description><language>en-us</language><lastBuildDate>3/11/2010 4:42:30 AM</lastBuildDate><pubDate>3/11/2010 4:42:30 AM</pubDate><ttl>5</ttl><webMaster>htais@ecri.org</webMaster><item><title>Study looks at experienced urologist's learning curve with da Vinci system</title><link>https://members2.ecri.org/Components/Forecast/Pages/11827.aspx</link><description> Robotic-assisted surgical procedures using the da Vinci Surgical System (Intuitive Surgical, Inc. Sunnyvale, CA, USA) are associated with a steep learning curve.</description><pubdate>2/19/2010</pubdate></item><item><title>No evidence for platelet rebound after clopidogrel cessation, study says</title><link>https://members2.ecri.org/Components/Forecast/Pages/11826.aspx</link><description> A recently published randomized, double-blind controlled trial published in the Journal of the American College of Cardiology (2010 Feb;55[6]:558-568) indicates that there is no evidence to show that a platelet rebound effect occurs after patients stop receiving treatment with clopidogrel, an antiplatelet medication commonly used after drug eluting stent (DES) implantation.</description><pubdate>2/19/2010</pubdate></item><item><title>MS drug gets stronger warning related to adverse events</title><link>https://members2.ecri.org/Components/Forecast/Pages/11825.aspx</link><description> The monoclonal antibody Tysabri (natalizumab, Biogen-Idec, Inc., Cambridge, MA, USA) used to treat multiple sclerosis (MS) has a new warning on its label related to the risk of developing progressive multifocal leukoencephalopathy (PML), a rare brain infection.</description><pubdate>2/19/2010</pubdate></item><item><title>Trial to test whether umbilical cord stem cells can treat cerebral palsy</title><link>https://members2.ecri.org/Components/Forecast/Pages/11824.aspx</link><description> Researchers at the Medical College of Georgia (MCG, Augusta, GA, USA) are initiating the first pediatric clinical trial with U.S. Food and Drug Administration approval to evaluate whether stem cells from umbilical cord blood can improve the quality of life for children with cerebral palsy (CP).</description><pubdate>2/19/2010</pubdate></item><item><title>Artificial pancreas shown to reduce risk of hypoglycemia in children</title><link>https://members2.ecri.org/Components/Forecast/Pages/11820.aspx</link><description> Researchers reported data from a small study in The Lancet that compared children and adolescents with type 1 diabetes mellitus (T1DM) using a closed-loop insulin delivery system.</description><pubdate>2/12/2010</pubdate></item></channel></rss>